Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Jul 2020
Historique:
received: 12 06 2020
revised: 02 07 2020
accepted: 09 07 2020
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 3 3 2021
Statut: epublish

Résumé

Collagen type 1 (COL1) is a ubiquitously existing extracellular matrix protein whose high density in breast tissue favors metastasis and chemoresistance. COL1-binding of MDA-MB-231 and MCF-7 breast cancer cells is mainly dependent on β

Identifiants

pubmed: 32668815
pii: ijms21144956
doi: 10.3390/ijms21144956
pmc: PMC7404217
pii:
doi:

Substances chimiques

ABCG2 protein, human 0
ATP Binding Cassette Transporter, Subfamily G, Member 2 0
Collagen Type I 0
ITGB4 protein, human 0
Indazoles 0
Integrin beta1 0
Integrin beta4 0
Itgb1 protein, human 0
Neoplasm Proteins 0
Piperazines 0
SCH772984 0
Doxorubicin 80168379AG
Mitoxantrone BZ114NVM5P
DDR1 protein, human EC 2.7.10.1
Discoidin Domain Receptor 1 EC 2.7.10.1
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1
Focal Adhesion Kinase 1 EC 2.7.10.2
PTK2 protein, human EC 2.7.10.2
MAPK1 protein, human EC 2.7.11.24
MAPK3 protein, human EC 2.7.11.24
Mitogen-Activated Protein Kinase 1 EC 2.7.11.24
Mitogen-Activated Protein Kinase 3 EC 2.7.11.24
Gefitinib S65743JHBS

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Ther Adv Med Oncol. 2020 Jan 28;12:1758835919897546
pubmed: 32064003
Mol Cell. 1997 Dec;1(1):13-23
pubmed: 9659899
Cancer Cell Int. 2018 Apr 2;18:50
pubmed: 29618949
Cancer Lett. 2019 Oct 1;461:102-111
pubmed: 31319139
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Breast Cancer Res. 2014;16(5):459
pubmed: 25606594
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938
Biochim Biophys Acta Mol Cell Res. 2019 Nov;1866(11):118473
pubmed: 30954568
Oncol Lett. 2016 Nov;12(5):3598-3608
pubmed: 27900042
J Cell Physiol. 2018 Aug;233(8):6280-6290
pubmed: 29521413
Cancer Res. 2006 Aug 15;66(16):8123-30
pubmed: 16912190
Sci Rep. 2020 Feb 20;10(1):3009
pubmed: 32080212
Cell Rep. 2018 Dec 26;25(13):3674-3692.e10
pubmed: 30590041
Drug Metab Dispos. 2018 May;46(5):567-580
pubmed: 29514827
Crit Rev Oncol Hematol. 2020 Jan;145:102855
pubmed: 31927455
Sci Rep. 2017 Apr 03;7:45895
pubmed: 28368050
Cancers (Basel). 2019 Jul 12;11(7):
pubmed: 31336983
Int J Cancer. 2015 Mar 15;136(6):E508-20
pubmed: 25155634
Sci Rep. 2016 Jan 05;6:18430
pubmed: 26728650
PLoS One. 2014 Aug 29;9(8):e105792
pubmed: 25170609
Sci Rep. 2015 Nov 09;5:16408
pubmed: 26549523
Front Pharmacol. 2019 May 03;10:462
pubmed: 31130862
Histopathology. 2008 Jan;52(1):108-18
pubmed: 18171422
Am J Cancer Res. 2016 Aug 01;6(8):1609-23
pubmed: 27648353
Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53
pubmed: 18938156
Respir Res. 2019 May 29;20(1):106
pubmed: 31142317
Elife. 2014 Mar 11;3:e01308
pubmed: 24618895
J Biol Chem. 2013 Mar 15;288(11):7430-7
pubmed: 23335507
EMBO J. 2003 Mar 17;22(6):1289-301
pubmed: 12628922
Fibrogenesis Tissue Repair. 2012 May 07;5(1):7
pubmed: 22564335
J Med Chem. 2013 Apr 25;56(8):3281-95
pubmed: 23521020
Cells. 2020 Feb 13;9(2):
pubmed: 32069815
BMC Cancer. 2014 Jan 02;14:1
pubmed: 24383403
Sci Rep. 2016 Nov 08;6:36336
pubmed: 27824116
Cancers (Basel). 2018 Dec 06;10(12):
pubmed: 30563275
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Invest New Drugs. 2013 Dec;31(6):1458-65
pubmed: 24068620
Cancers (Basel). 2017 Sep 16;9(9):
pubmed: 28926938
Breast Cancer Res Treat. 2015 Feb;150(1):9-18
pubmed: 25667101
BMC Cancer. 2018 Jan 6;18(1):41
pubmed: 29304770
Cell Mol Life Sci. 2011 Nov;68(22):3757-70
pubmed: 21499918
BMC Cancer. 2017 Jan 31;17(1):87
pubmed: 28143619
Ther Adv Med Oncol. 2014 Jul;6(4):154-66
pubmed: 25057302
J Invest Dermatol. 2010 Jan;130(1):74-85
pubmed: 19675578
Oncol Lett. 2018 Mar;15(3):3403-3408
pubmed: 29467865
Discov Med. 2018 May;25(139):211-223
pubmed: 29906404
Cell Adh Migr. 2018;12(4):324-334
pubmed: 29616590
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3748-3758
pubmed: 32015106
Blood. 1999 Mar 1;93(5):1658-67
pubmed: 10029595
Eur J Med Chem. 2016 Nov 29;124:881-895
pubmed: 27676469
Exp Cell Res. 2006 Dec 10;312(20):4011-8
pubmed: 17027969
JAMA. 2019 Jan 22;321(3):288-300
pubmed: 30667505
Cell Rep. 2015 Apr 21;11(3):390-404
pubmed: 25865888
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Nat Rev Cancer. 2009 Sep;9(9):665-74
pubmed: 19693095
Med Oncol. 2012 Jun;29(2):401-5
pubmed: 21264531
Mol Cancer Ther. 2017 Nov;16(11):2473-2485
pubmed: 28864681
Matrix Biol. 2014 Feb;34:185-92
pubmed: 24361528
Biochim Biophys Acta Mol Cell Res. 2020 May;1867(5):118663
pubmed: 31987794
Front Pharmacol. 2016 Mar 14;7:55
pubmed: 27014069
Cancers (Basel). 2018 Nov 28;10(12):
pubmed: 30487436
Eur J Cancer. 2002 Dec;38(18):2362-70
pubmed: 12460779
PLoS One. 2012;7(12):e52209
pubmed: 23284937
Oncotarget. 2017 Jun 28;8(40):67553-67566
pubmed: 28978053
Methods Mol Biol. 2014;1204:145-53
pubmed: 25182768
Int Rev Cell Mol Biol. 2014;310:39-87
pubmed: 24725424
Mod Pathol. 2014 Sep;27(9):1212-22
pubmed: 24406864
Blood. 2013 Dec 19;122(26):4237-45
pubmed: 24136166
J Ovarian Res. 2017 Jul 25;10(1):50
pubmed: 28743276

Auteurs

Fabian Baltes (F)

Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn 53123, Germany.

Julia Caspers (J)

Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn 53123, Germany.

Svenja Henze (S)

Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn 53123, Germany.

Martin Schlesinger (M)

Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn 53123, Germany.

Gerd Bendas (G)

Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn 53123, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH